US4693999A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Liposomes containing steroid esters
Assignee: Draco AB
•
Filing: 1985-07-03
•
Granted: 1987-09-15
•
Expires: 2005-07-03
Abstract
Abstract Pharmaceutical composition for administration primarily to the respiratory tract when treating and controlling anti-inflammatory conditions comprising liposomes in combination with a compound of the formula ##STR1## and R 1 is a saturated or unsaturated, straight or branched alkyl group with 11-19 carbon atoms and R is H, --COCH 3 , --COC 2 H 5 , --CO(CH 2 ) 2 CH 3 or --CO(CH 2 ) 3 CH 3 . The invention also refers to the compounds of the formula I per se processes for preparation of these compounds and to a method for the treatment of inflammatory conditions.
Inventors
- 👤 Bengt I. Axelsson
- 👤 Ralph L. Brattsand
- 👤 Carl M. O. Dahlback
- 👤 Leif A. Kallstrom
- 👤 Jan W. Trofast
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-23 11:42
CPC Classifications
A; A61; A61K; A61K31/00; A61K31/56; A61K31/57; A61K31/58; A61K9/00; A61K9/10; A61K9/127; A61P; A61P5/00; A61P5/38; C; C07; C07J; C07J5/00; C07J5/0046; C07J5/0061; C07J5/0069; C07J5/0076; C07J71/00; C07J71/0005; C07J71/0026; C07J71/0031
Claims Analysis
Total Claims: 9
Claim 1
Independent Claim
71 words
A pharmaceutical composition for administration primarily to the respiratory tract comprising liposomes in combination with an antiinflammatory and antiallergic effective amount of a compound of the formula ##STR6## and R 1 is a saturated or unsaturated, straight or branched alkyl group with 11-19 carbon atoms and R is H, --COCH 3 , --COC 2 H 5 , --CO(CH 2 ) 2 CH 3 or --CO(CH 2 ) 3 CH 3 .
Claim 2
Dependent Claim
71 words
A pharmaceutical composition for administration primarily to the respiratory tract comprising liposomes in combination with an antiinflammatory and antiallergic effective amount of a compound of the formula ##STR6## and R 1 is a saturated or unsaturated, straight or branched alkyl group with 11-19 carbon atoms and R is H, --COCH 3 , --COC 2 H 5 , --CO(CH 2 ) 2 CH 3 or --CO(CH 2 ) 3 CH 3 .
Claim 3
Dependent Claim
43 words
A composition according to claim 1 wherein the compound of formula I is ##STR7## in the form of a stereoisomeric mixture or an epimer of the R or S type regarding the orientation of the substituents on the carbon atom at position 22.
Claim 4
Dependent Claim
20 words
A composition according to claim 1 which consists of a lyophilized liposome preparation containing a compound of the formula I.
Claim 5
Dependent Claim
80 words
A process for the preparation of a pharmaceutical composition according to claim 1 characterized in (a) dissolving a compound of the formula I defined in claim 1 and a lecithin in an organic solvent, (b) evaporating the solvent and thus obtaining the liposomes directly in an aqueous atmosphere, or (c) after evaporation, dispersing the lipid layers in an aqueous (with or without lactose) medium and (d) shaking or sonicating the obtained suspension or alternatively (e) drying of the liposome suspension.
Claim 6
Dependent Claim
49 words
A compound of the formula ##STR8## and R 1 is a saturated or unsaturated straight or branched alkyl group with 11-19 carbon atoms and R is H, --COCH 3 , --COC 2 H 5 , --CO(CH 2 ) 2 CH 3 or --CO(CH 2 ) 3 CH 3 .
Claim 7
Dependent Claim
49 words
A compound of the formula ##STR8## and R 1 is a saturated or unsaturated straight or branched alkyl group with 11-19 carbon atoms and R is H, --COCH 3 , --COC 2 H 5 , --CO(CH 2 ) 2 CH 3 or --CO(CH 2 ) 3 CH 3 .
Claim 8
Dependent Claim
43 words
A compound according to claim 5 wherein the compound of formula I is ##STR9## in the form of a stereoisomeric mixture or an epimer of the R or S type regarding the orientation of the substituents on the carbon atom at position 22.
Claim 9
Dependent Claim
36 words
A method for the treatment and control of inflammatory conditions in mammals, including man, characterized by the administration to a host in need of such treatment and effective amount of a composition according to claim 1.
References Cited (Backward Citations)
SE378109B
Cited
GB1523965A
Cited
US4427649A
Cited
GB1575343A
Cited
US4229360A
Cited
US4229360B1
Cited
US4247411A
Cited
EP0041772A2
Cited
DE3228629A1
Cited
GB2135647A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1990-09-14 | 1991-03-16 | 1991-09-15 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1994-09-14 | 1995-03-16 | 1995-09-15 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 1998-09-14 | 1999-03-16 | 1999-09-15 | $7700.00 | Window Closed / Lapsed |